Is AbbVie, Inc. (ABBV) a buy?

Based on 5 suggestions, AbbVie, Inc.(ABBV) is recommended as a STRONG BUY.
The top analysis was written by Dividend Diplomats Blog titled Dividend Income Summary: Lanny’s November 2022 Summary
The top analysis is chosen based on the user's overall performance, volatility management, and diversification

Forecast for AbbVie, Inc. (ABBV)

Based on the most recent price of $158.25,
the two year forecast for ABBV is $189.90.
The four year forecast is $221.55
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.